Home/Virtech Bio/Matias Vidal

MV

Matias Vidal

Co-Founder & Executive Chairman

Therapeutic Areas

Trauma/Hemorrhagic Shock Organ Transplantation

Virtech Bio Pipeline

Drug	Indication	Phase
OxyBridge™ for Organ Perfusion	Ex vivo perfusion of donor organs prior to transplantation	Pre-clinical
OxyBridge™ for Hemorrhagic Shock	Treatment of severe blood loss in trauma	Pre-clinical

Leadership Team at Virtech Bio

COL(R) Dallas Hack, MD, MPH

CEO & Director, Medical Affairs

W. Richard Light, PhD

Chief Scientific Officer

Martha Farmer, PhD

Executive VP & Board Member

View full Virtech Bio profile